SEC Form 4 · accession 0001638986-15-000001
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Queena Han
Officer — VP Finance / HR
Period of report
Dec 18, 2015
Accepted (ET)
Dec 22, 2015 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Dec 18, 2015 | M | 10,000 | $0.72 | A | 10,000 | D | |
| Common SharesF1 | Dec 18, 2015 | S | 7,700 | $10.51 | D | 2,300 | D | |
| Common SharesF2 | Dec 18, 2015 | S | 2,300 | $11.055 | D | 0 | D | |
| Common Shares | Dec 21, 2015 | M | 10,000 | $0.72 | A | 10,000 | D | |
| Common SharesF3 | Dec 21, 2015 | S | 7,110 | $10.1058 | D | 2,890 | D | |
| Common SharesF4 | Dec 21, 2015 | S | 2,890 | $10.645 | D | 0 | D | |
| Common Shares | Dec 22, 2015 | M | 10,000 | $0.72 | A | 10,000 | D | |
| Common SharesF5 | Dec 22, 2015 | S | 10,000 | $10.2743 | A | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $0.72 | Dec 18, 2015 | M | 10,000 | D | Dec 10, 2007 | Dec 10, 2016 | Common Shares | 10,000 | 40,000 | D |
| Stock Option | $0.72 | Dec 21, 2015 | M | 10,000 | D | Dec 10, 2007 | Dec 10, 2016 | Common Shares | 10,000 | 30,000 | D |
| Stock Option | $0.72 | Dec 22, 2015 | M | 10,000 | D | Dec 10, 2007 | Dec 10, 2016 | Common Shares | 10,000 | 20,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $10.23 to $10.70. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
- F2This transaction was executed in multiple trades at prices ranging from $10.76 to $11.33. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
- F3This transaction was executed in multiple trades at prices ranging from $9.8 to $10.36. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
- F4This transaction was executed in multiple trades at prices ranging from $10.39 to $10.97. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
- F5This transaction was executed in multiple trades at prices ranging from $10.01 to $10.7359. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
Remarks
Stock Options were vested 50% over 2 years with vesting date of 12/10/2006